Statement from FDA Confirms Approval of Gilead's Zydelig

By: via Benzinga
The U.S. Food and Drug Administration today approved Zydelig (idelalisib) to treat patients with three types of blood ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.